Articles liés à Benign Prostatic Hyperplasia : An Overview: Various...

Benign Prostatic Hyperplasia : An Overview: Various treatment options for enlarged prostate - Couverture souple

Dhingra, Neelima; Bhardwaj, Tilak Raj

 
9783659191039: Benign Prostatic Hyperplasia : An Overview: Various treatment options for enlarged prostate
Couverture souple
ISBN 10 : 3659191035 ISBN 13 : 9783659191039
Editeur : LAP LAMBERT Academic Publishing, 2012

Synopsis

Benign prostatic hyperplasia and its clinical manifestation as lower urinary tract symptoms is a major health concern for aging men. A better understanding of the prostate physiology, function, and pathogenesis has led to the development of number of promising agents.The specific approach used to treat BPH depends upon number of factors like age,prostrate size, weight,prostate-specific antigen level,and severity of the symptoms. 5α-reductase inhibitors decrease the production of dihydrotestosterone within the prostate,which results in decreased prostate volume, improvement of symptoms,and need for surgical intervention. α1-adrenergic receptor antagonists decrease LUTS and increase urinary flow rates in men with symptomatic BPH,but do not reduce the long-term risk of urinary retention.Clinical efficacy of either 5α-RI or α1-AR antagonist has been further improved by using combination therapy;however,long-term outcomes are still awaited. Many more potential new therapies are under development that may improve the treatment of BPH.This book gives a brief account of physiology,diagnosis, rationale and efficacy of different treatment options presently available in the management of BPH.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

Benign prostatic hyperplasia and its clinical manifestation as lower urinary tract symptoms is a major health concern for aging men. A better understanding of the prostate physiology, function, and pathogenesis has led to the development of number of promising agents.The specific approach used to treat BPH depends upon number of factors like age,prostrate size, weight,prostate-specific antigen level,and severity of the symptoms. 5α-reductase inhibitors decrease the production of dihydrotestosterone within the prostate,which results in decreased prostate volume, improvement of symptoms,and need for surgical intervention. α1-adrenergic receptor antagonists decrease LUTS and increase urinary flow rates in men with symptomatic BPH,but do not reduce the long-term risk of urinary retention.Clinical efficacy of either 5α-RI or α1-AR antagonist has been further improved by using combination therapy;however,long-term outcomes are still awaited. Many more potential new therapies are under development that may improve the treatment of BPH.This book gives a brief account of physiology,diagnosis, rationale and efficacy of different treatment options presently available in the management of BPH.

Biographie de l'auteur

Author is an academician by profession with 5 yr of experience.She is specialist in synthesis and studies of medicinally important molecules.She has earned Bachelor,Masters and Ph.D in Pharmaceutical Sciences from the University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh.Her Research work has received 5 national awards.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
LAP LAMBERT Academic Publishing
Date d'édition
2012
Langue
anglais
ISBN 10 
3659191035
ISBN 13 
9783659191039
Reliure
Broché
Nombre de pages
64
Coordonnées du fabricant
non disponible
Personne responsable
KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne